Skip to main content

Cardiovascular News

News
Sanofi-Aventis US issued a precautionary, voluntarily recall of all over-the-counter Zantac (ranitidine) products because of possible contamination with N-Nitrosodimethylamine (NDMA), a probable human carcinogen. The recalls were listed in the December 11, 2019, US Food and Drug Administration (FDA…
News
By Reuters Staff (Reuters) - Dr. Stephen Hahn was on Thursday confirmed as the new head of the U.S. Food and Drug Administration, taking charge at a regulatory agency that oversees products ranging from complex cancer drugs, to food, cosmetics and tobacco. Hahn takes over as the FDA commissioner…
News
AuroMedics Pharma is recalling numerous lots of amiodarone hydrochloride injection because of crystallization, according to the December 4, 2019, US Food and Drug Administration (FDA) Enforcement Report.  The recall includes the following products, which were distributed throughout the United…
News
AvKARE Inc. and AuroMedics Pharma have joined a number of companies voluntarily recalling ranitidine products because of contamination with the probable human carcinogen N-Nitrosodimethylamine (NDMA). The latest recalls were announced in the December 4, 2019, US Food and Drug Administration (FDA)…
News
Preferred Pharmaceuticals Inc. is voluntarily recalling several lots of prescription ibuprofen oral suspension, 100 mg/5 mL, 4 fluid ounces (118 mL, NDC 68788-7268-01), distributed in California, Florida, and Illinois. According to the December 4, 2019, US Food and Drug Administration (FDA)…
News
By Carl O'Donnell and Ludwig Burger (Reuters) - The U.S. Food and Drug Administration and other healthcare regulators are investigating whether diabetes drug metformin had contaminations of a cancer-causing chemical that prompted a recall of a commonly used heartburn medication this year. The…
News
By Tamara Mathias and Vishwadha Chander (Reuters) - Privately held drug developer Enzyvant said on Thursday the U.S. Food and Drug Administration declined to approve its regenerative tissue therapy for a rare immunodeficiency disorder and raised concerns about its manufacturing. The company was…
News
More than a dozen companies received warning letters from the US Food and Drug Administration (FDA) this week about illegally selling products containing cannabidiol (CBD), the FDA stated in a November 25, 2019, announcement.   “We remain concerned that some people wrongly think that the myriad of…
News
X-Gen Pharmaceuticals Inc. is recalling 25,120 vials of levetiracetam injection because they contain the wrong package insert, according to the November 27, 2019, US Food and Drug Administration (FDA) Enforcement Report.  The recall affects levetiracetam injection, 500 mg/5 mL, 10 single-use 5-mL…
News
Dark-colored particles found during stability testing have prompted Teva Pharmaceuticals USA Inc. to voluntarily recall two lots of 100-mL bottles of valganciclovir hydrochloride for oral solution, 50 mg/mL, according to the November 27, 2019, US Food and Drug Administration (FDA) Enforcement…
Back to Top